Antihypertensive treatment and control in a large primary care population of 21 167 patients

Journal of Human Hypertension

Volumn 25, Issue 8, 2011, Pages 484-491

  Qvarnstrom M ^a   Wettermark, B ^a,b   Ljungman, C ^c   Zarrinkoub, R ^b   Hasselstrom J ^a,b   Manhem, K ^c   Sundstrom A ^a   Kahan, T ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

Author keywords

age; drug therapy; gender; primary health care

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DATA BASE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; MALE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 79960450695     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.86     Document Type: Article

References (36)

1. Lindholm LH, Agenäs I, Carlbeg B, Dahlgren H, de Faire U, Hedblad B et al. Moderately Elevated Blood Pressure. A Systematic Literature Review. The Swedish Council on Technology Assessment in Health Care: Stockholm, 2004. Report 170/1, pp 1-248 & 170/2, pp 1-514.
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-2369. (Pubitemid 37430168)
3. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818-827.
4. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360. (Pubitemid 35341298)
5. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-2544. (Pubitemid 37430155)
6. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21: 1055-1076. (Pubitemid 36667856)
7. Weinehall L, Ohgren B, Persson M, Stegmayr B, Boman K, Hallmans G et al. High remaining risk in poorly treated hypertension: the rule of halves still exists. J Hypertens 2002; 20: 2081-2088. (Pubitemid 35305507)
8. Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlöv P, Brunkstedt I et al. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care 2006; 24: 224-230. (Pubitemid 44836164)
9. Journath G, Hellénius ML, Petersson U, Theobald H, Nilsson PM, Hyper-Q Study Group Sweden. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden. Eur J Cardiovasc Prev Rehabil 2008; 15: 258-262.
10. McInnis NH, Fodor G, Lum-Kwong MM, Leenen FH. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP). Am J Hypertens 2008; 21: 1210-1215.
11. Abaci A, Kozan O, Oguz A, Sahin M, Deger N, Senocak H et al. Prescribing pattern of antihypertensive drugs in primary care units in Turkey: results from the TURKSAHA study. Eur J Clin Pharmacol 2007; 63: 397-402. (Pubitemid 46399133)
12. Westheim A, Klemetsrud T, Tretli S, Stoikke HP, Olsen H. Blood pressure levels in treated hypertensive patients in general practice in Norway. Blood Press 2001; 10: 37-42. (Pubitemid 32288580)
13. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898. (Pubitemid 351620109)
14. Ljungman C, Mortensen L, Kahan T, Manhem K. Treatment of mild to moderate hypertension by gender perspective. J Women Health 2009; 18: 1049-1062.
15. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
16. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo Jr JL et al. American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115: 2761-2788. (Pubitemid 46842793)
17. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32(Suppl 1): 13-61.
18. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ et al. Reappraisal of European guidelines of hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2159.
19. Engfeldt P, Popa C, Bergensand P, Bernsten C, Lindgren O, Navay I et al. Quality assurance of drug prescription in primary health care. A new database software makes the drug therapy surveillance easier. Läkartidningen 2001; 98: 5767-5771. (Pubitemid 33742055)
20. Cederholm J, Nilsson PM, Anderberg C-P, Fröberg L, Petersson U, for the Q-Heart Study Group. Blood pressure and other cardiovascular risk factors among treated hypertensives in Swedish primary health care. Scand J Prim Health Care 2002; 20: 224-229. (Pubitemid 36109408)
21. Fagard RH, van den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20: 1297-1302. (Pubitemid 34925673)
22. Khan N, Chockalingam A, Campbell NR. Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol 2002; 18: 657-661.
23. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Br Med J 2009; 338: 1245-1252.
24. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366: 1545-1553. (Pubitemid 41540112)
25. Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a metaanalysis. CMAJ 2006; 174: 1737-1742. (Pubitemid 43893565)
26. Wettermark B, Godman B, Neovius M, Hedberg N, Mellgren T-O, Kahan T. Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment. Health Policy 2010; 94: 221-229.
27. Borzecki AM, Glickman ME, Kader B, Berlowitz DR. The effect of age on hypertension control and management. Am J Hypertens 2006; 19: 520-527.
28. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Sex differences in hypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens 1998; 16: 1545-1553. (Pubitemid 28470505)
29. Jochmann N, Stangl K, Garbe E, Baumann E, Stangl V. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 2005; 26: 1585-1595. (Pubitemid 41389688)
30. Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdó ttir S. The gap between guidelines and reality: type 2 diabetes in a National Diabetes Register 1996-2003. Diabet Med 2005; 22: 1420-1426. (Pubitemid 41391321)
31. Buckley B, Shanahan E, Colwell N, Turgonyi E, Bramlage P, Perry IJ. Blood pressure control in hypertensive patients in Irish primary care practices. J Clin Hypertens (Greenwich) 2009; 11: 432-440.
32. Dahlö f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005 366 895-906. (Pubitemid 41265663)
33. Jamerson K, Weber MA, Bakris GL, Dahlö f B, Pitt B, Shi V et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428.
34. Nietert PJ,Wessell AM, Feifer C, Ornstein SM. Effect of terminal digit preference on blood pressure measurement and treatment in primary care. Am J Hypertens 2006; 19: 147-152. (Pubitemid 43350165)
35. Burnier M, Gasser UE. End-digit preference in general practice: a comparison of the conventional auscultatory and electronic oscillometric methods. Blood Press 2008; 17: 104-109. (Pubitemid 351891176)
36. Cramer JA, Benedict A, Muszabek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 2008; 62: 76-87. (Pubitemid 350294021)